About: Azithromycin was cost-effective for genital Chlamydia trachomatis infections

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Azithromycin was cost-effective for genital Chlamydia trachomatis infections Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebm/1996/volume_1/issue_5/w
Subject	Economics
Title	Azithromycin was cost-effective for genital Chlamydia trachomatis infections
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebm/1996/volume_1/issue_5/B3555EDB3D5238C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebm/1996/volume_1/issue_5/B3555EDB3D5238C5E053120B220A16A6/m/web
Abstract	MagidDDouglasJMJrSchwartzJS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med. 1996 Feb 15;124:389-99.
article type	other
publisher identifier	ebmed1160
is part of this journal	Evidence Based Medicine

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata